Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice

  • Florence Njau,
  • Nelli Shushakova,
  • Heiko Schenk,
  • Vera Christine Wulfmeyer,
  • Robin Bollin,
  • Jan Menne,
  • Hermann Haller

The following information is missing from the Funding statement: This work was also supported by a grant from the Else-Kröner-Fresenius Foundation to HA: Projekt 2017_A96.

Reference

  1. 1. Njau F, Shushakova N, Schenk H, Wulfmeyer VC, Bollin R, Menne J, et al. (2020) Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice. PLoS ONE 15(1): e0218494. https://doi.org/10.1371/journal.pone.0218494 pmid:31935212

Citation: Njau F, Shushakova N, Schenk H, Wulfmeyer VC, Bollin R, Menne J, et al. (2020) Correction: Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice. PLoS ONE 15(12): e0244353. https://doi.org/10.1371/journal.pone.0244353

Published: December 16, 2020

Copyright: © 2020 Njau et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.